Loading
Life sciences · Journal article
Medical Gas Research · May 21, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Hyperbaric oxygen therapy is established for decompression illness, carbon monoxide poisoning, radiation-induced tissue injury, and diabetic foot ulcers. Interest in neurological and inflammatory indications is growing, yet outcomes are constrained by heterogeneous protocols, limited patient selection tools, and the absence of real-time physiological guidance. Artificial intelligence, including machine learning, explainable artificial intelligence, and digital twins, has transformed other clinical domains and could enable precision hyperbaric oxygen therapy. We searched PubMed, Scopus, Web of Science, and Google Scholar (January 2000-March 2025). Terms included "hyperbaric oxygen therapy" and ("artificial intelligence" OR "machine learning" OR "deep learning" OR "digital twin" OR "biosensor*"). English-language, peer-reviewed clinical, preclinical, or computational studies explicitly linking hyperbaric oxygen therapy with artificial intelligence or enabling technologies were eligible. Editorials without primary data, abstracts without full text, and non-peer-reviewed sources were excluded. A Preferred Reporting Items for Systematic Reviews and Meta-Analyses-style flow-guided screening and selection. Fifty-three eligible studies (≥30% from 2022-2025) illustrate four convergent application areas: (1) protocol optimization using multicenter data, (2) biomarker-driven patient selection via multi-omics and imaging, (3) real-time adaptive control using biosensors, and (4) predictive safety analytics for oxygen toxicity and barotrauma. Exemplars from radiology, critical care, and cardiology demonstrate the feasibility of decision support, federated learning, and digital-twin simulations adaptable to hyperbaric oxygen therapy. Integrating artificial intelligence with hyperbaric oxygen therapy can shift practice from empirical protocols to patient-tailored, data-informed therapy. Priorities include hybrid clinical trials, interoperable registries, explainable and bias-aware models, and regulatory-aligned validation. With rigorous governance, artificial intelligence can improve efficacy, safety, and efficiency while advancing mechanistic understanding of hyperbaric oxygen therapy.